The increased tumour uptake of [18F]AlF-mNOTA-GZP in TRs was associated with a robust increase in tumour-associated activated T cells, especially GZB+ CD8+ cells, GZB+ CD45+ cells and CD25+ CD4 cells (Figure 3) are in line with previously reported data [34,35]. The gene discussed is CD8A; the disease is neoplasm.